2026-23141NoticeWallet

FDA Says Dibenzyline Wasn't Pulled for Safety or Effectiveness

Published Date: 11/13/2026

Notice

Summary

The FDA has decided that Dibenzyline (Phenoxybenzamine Hydrochloride) 10 mg capsules and some other drugs weren’t taken off the market because they’re unsafe or don’t work. This means generic versions can keep getting approved as long as they meet the rules. Patients and drug makers can breathe easy knowing these meds stay on the list and available.

Analyzed Economic Effects

4 provisions identified: 3 benefits, 1 costs, 0 mixed.

Generic Approvals Can Continue

The FDA says it will continue to allow abbreviated new drug applications (ANDAs) that refer to the listed drugs to be approved if they meet legal and regulatory requirements. This specifically includes drugs listed in the notice such as DIBENZYLINE (Phenoxybenzamine Hydrochloride) 10 mg (NDA 008708).

Existing Generic Approvals Unchanged

Approved ANDAs that refer to the listed drug products are unaffected by the products' discontinued marketing. For example, ANDAs that reference DIBENZYLINE (Phenoxybenzamine Hydrochloride) 10 mg (NDA 008708) remain approved.

Products Listed as Discontinued (Not Safety Issues)

The FDA will continue to list the named products in the Orange Book's "Discontinued Drug Product List," which identifies drugs discontinued from marketing for reasons other than safety or effectiveness. The notice names multiple products, including DIBENZYLINE (NDA 008708) and others on the table in the document.

Possible Labeling Revisions for Applicants

The FDA says that if it determines labeling for these drug products should be revised to meet current standards, the Agency will advise ANDA applicants to submit such labeling. This applies to the drugs named in the notice, for example DIBENZYLINE (NDA 008708).

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
11/13/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register